The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke
Understanding the Relationship Between Controlling Risk Factors and Cerebral Haemodynamic Changes in Lacunar Stroke, and Its Interaction With Ageing
University of Leicester
75 participants
May 2, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to look at differences in brain blood flow before and after management of risk factors such as high blood pressure and diabetes in patients with lacunar stroke. Participants will be asked to undergo a simple brain blood flow assessment at their initial appointment, whereby they will be asked to sit and stand twice. The patients will then be asked for a follow-up assessment 4 weeks after, identical to the first. This will allow us to look at any changes in brain blood flow from before management of risk factors and 4 weeks after management of risk factors.
Eligibility
Inclusion Criteria3
- Adults aged between 18-120 years.
- Diagnosis of lacunar stroke syndrome.
- New diagnosis or known diagnosis of hypertension and/or diabetes.
Exclusion Criteria2
- Those who lack capacity can have a personal consultee consent to the study if they can still perform study requirements such as the sit-stand manoeuvre. Those who either cannot perform the manoeuvre or do not have a personal consultee to allow them to consent, are not able to take part.
- Those with poorly controlled medical comorbidities affecting cerebral haemodynamics. (eg., heart failure).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
TCD will be used to measure the cerebral blood flow in the middle and posterior cerebral arteries. This will be done at rest and during two sit-stand manoeuvres, whereby the participant will be asked to stand (from a seated position) and stay standing for 1 minute. The participant will then be given time to recover before repeating the manoeuvre. This will occur at the first visit and the follow-up visit 4 weeks after.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06354881